unknown
Stage
About
Akagera Medicines develops novel and patented liposomal formulations of antibacterial drugs targeting tuberculosis and other infectious diseases, with operations based in Rwanda and laboratories in the US.
Explore Akagera Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.